Try a new search

Format these results:

Searched for:



Total Results:


Sickle cell disease -- when opioids and physicians fail [Case Report]

Malach, Stephen; Levin, Tomer; Saravay, Stephen; Martin, Robert; Rao, Sandyha; Horowitz, Deborah
An interview with a 32-year-old male with sickle cell anemia and multiple sequential admissions for vaso-occlusive crises, receiving high dose narcotic analgesics, is presented. The subsequent clinical discussion outlines psychiatric, psychosocial and treatment issues. Management of acute vaso-occlusive crisis is summarized along with a discussion of the value of comprehensive care for sickle cell disease patients. This article will be useful to physicians and consultation-liaison psychiatrists treating patients with sickle cell disease as well as policy makers developing service delivery models for this population.
PMID: 12490348
ISSN: 0163-8343
CID: 161585

Mesenchymal to epithelial conversion in rat metanephros is induced by LIF

Barasch, J; Yang, J; Ware, C B; Taga, T; Yoshida, K; Erdjument-Bromage, H; Tempst, P; Parravicini, E; Malach, S; Aranoff, T; Oliver, J A
Inductive signals cause conversion of mesenchyme into epithelia during the formation of many organs. Yet a century of study has not revealed the inducing molecules. Using a standard model of induction, we found that ureteric bud cells secrete factors that convert kidney mesenchyme to epithelia that, remarkably, then form nephrons. Purification and sequencing of one such factor identified it as leukemia inhibitory factor (LIF). LIF acted on epithelial precursors that we identified by the expression of Pax2 and Wnt4. Other IL-6 type cytokines acted like LIF, and deletion of their shared receptor reduced nephron development. In situ, the ureteric bud expressed LIF, and metanephric mesenchyme expressed its receptors. The data suggest that IL-6 cytokines are candidate regulators of mesenchymal to epithelial conversion during kidney development.
PMID: 10571180
ISSN: 0092-8674
CID: 2457372